Study of a new tumor marker, CYFRA 21-1, in malignant and nonmalignant diseases.

@article{Molina1994StudyOA,
  title={Study of a new tumor marker, CYFRA 21-1, in malignant and nonmalignant diseases.},
  author={Rafael I. Molina and Carles Agust{\'i} and Xavier Filella and Judith Jo and Jacob Joseph and Nuria Gim{\'e}nez and Antonio Manuel Ballesta},
  journal={Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine},
  year={1994},
  volume={15 6},
  pages={318-25}
}
The diagnostic value of a new tumor marker, CYFRA 21-1, was studied in the sera of 50 controls, 206 patients with benign diseases and 469 patients with malignancies. Fifty controls showed mean serum concentrations of 1.2 +/- 0.5 ng/ml. Using 3.3 ng/ml as the cutoff, abnormal CYFRA levels were found in 13.1% of patients with benign diseases, mainly in those with liver cirrhosis (29.4%) or renal failure (20.8%), and in 44.4% (180/405) of patients with active cancer. Neither healthy subjects nor… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Similar Papers

Loading similar papers…